Empresa RepliCel Life Sciences Inc.
Acciones
REPCF
CA76027P4006
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,0428 USD | +4,99 % | -.--% | -4,89 % |
Resumen de negocios
Número de empleados: 1
Ventas por actividad
CAD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Cell Replication Technology
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Ventas por región
CAD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Andrew Schutte
CEO | Chief Executive Officer | 35 | 14/12/18 |
Rolf Hoffmann
FOU | Founder | 63 | - |
Kevin McElwee
FOU | Founder | 54 | - |
David Kwok
DFI | Director of Finance/CFO | - | 16/08/23 |
David Hall
CHM | Chairman | 71 | 22/12/10 |
Ben Austring
COO | Chief Operating Officer | 41 | 28/11/22 |
Robert Buckler
BRD | Director/Board Member | 58 | 01/10/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 22/12/10 |
Peter Lewis
BRD | Director/Board Member | 69 | 27/05/11 |
Rolf Hoffmann
FOU | Founder | 63 | - |
Robert Buckler
BRD | Director/Board Member | 58 | 01/10/14 |
Gary Boddington
BRD | Director/Board Member | 56 | 01/06/21 |
Andrew Schutte
CEO | Chief Executive Officer | 35 | 14/12/18 |
Peter Lowry
BRD | Director/Board Member | 61 | 14/12/18 |
Jamie Mackay
BRD | Director/Board Member | - | 09/08/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 61 426 772 | 24 249 871 ( 39,48 %) | 0 | 39,48 % |
Información de la empresa
RepliCel Life Sciences, Inc.
570 Granville Street Suite 900
V6C 3P1, Vancouver
+604 248 8730
http://www.replicel.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
-4,89 % | 2,78 M | |
+3,91 % | 109 mil M | |
+10,87 % | 105 mil M | |
+1,28 % | 22,25 mil M | |
-13,14 % | 22,09 mil M | |
-7,05 % | 18,68 mil M | |
-38,36 % | 17,58 mil M | |
-10,66 % | 16,85 mil M | |
+3,75 % | 13,76 mil M | |
+36,70 % | 12,46 mil M |
- Bolsa de valores
- Acciones
- Acción REPCF
- Empresa RepliCel Life Sciences Inc.